ArticleCureus2025
Griscelli Syndrome Type 2 Revealed by Macrophage Activation Syndrome: Two Cases From the Same Family.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Griscelli syndrome type 2 is a rare autosomal recessive disorder caused by mutations in the RAB27A gene. It is characterized by partial albinism, a silvery sheen of the hair, and an immune deficiency. We report cases of two siblings, a seven-year-old boy and his 10-year-old sister, who were admitted to the emergency department with sepsis complicated by macrophage activation syndrome. Their clinical course was rapidly unfavorable. The diagnosis of Griscelli syndrome type 2 was made in the light of a combination of clinical and biological arguments: oculocutaneous hypopigmentation, silvery sheen of the hair, the absence of psychomotor delay, the occurrence of a macrophage activation syndrome following an infection, and especially the pathognomonic appearance on microscopic examination of a hair sample. The absence of giant granulations in the nucleated cells made it possible to eliminate Chediak-Higashi syndrome. Griscelli syndrome type 2 should be considered in children presenting with hypopigmentation, silvery hair, and immune dysregulation, particularly when complicated by macrophage activation syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.